The conversation discusses the availability and legitimacy of a hair loss treatment called PP405-3HP. Users express skepticism about its release and reference patent information.
The conversation is about starting a hair loss treatment using a topical solution containing RU58841, Minoxidil, and Copper Peptides. The user plans to test the product and share updates on its effectiveness.
The user switched from finasteride to dutasteride, experienced continuous hair shedding, and was advised by a dermatologist to switch back to finasteride. The user plans to stick with finasteride and oral minoxidil, noting that dutasteride may cause prolonged shedding and potential side effects like gynecomastia.
The user used finasteride but stopped due to side effects, then used topical minoxidil for 13 months, and later added KX826/pyrilutamide for 8 months. They experienced shedding after starting pyrilutamide and use minoxidil and KX826 once daily.
The conversation is about sourcing and using topical melatonin for retrograde alopecia. Users discuss purchasing options and potential benefits for hair growth.
Longitudinal partial follicular unit transplantation involves extracting part of the donor follicular unit, allowing the donor area to be overharvested without noticeable hair loss. The conversation questions if this method is practiced in clinics or if it's theoretical, and whether it relates to hair cloning or multiplication.
A 22-year-old male has been using oral dutasteride, oral minoxidil, topical minoxidil, and supplements for hair loss, experiencing shedding but some regrowth on the temples. Despite concerns about starting dutasteride, he is seeing positive results and hopes for long-term success.
Increasing dutasteride from 3x to 5x a week led to worse hair loss and higher DHT levels, prompting a return to the original dosing. The user also uses topical minoxidil and is addressing a folic acid deficiency.
The user experienced hair loss after switching from topical to oral minoxidil and adding dutasteride, leading to doubts about its effectiveness. They are considering returning to RU58841 or topical minoxidil due to continued shedding and mental distress.
The user has been using finasteride, dutasteride, minoxidil, and RU58841 for hair loss but is experiencing worsening hair density despite treatment. They are frustrated and confused as their hairline remains unchanged, but the overall hair thickness has decreased significantly.